Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study

by Hongming Pan, Yi-Long Wu, Qingyuan Zhang, Ying Yuan, Yuxian Bai, Tianshu Liu, Xiaoming Huang, Siyang Wang, Aiping Zhou, Dingwei Ye, Yujuan Gao, Silu Yang, Zoubai Wang
Published 2020-06-01